In Vivo - Strategic Analysis For Medtech And Pharma Leaders since 1981

Podcasts


Innovation


Failing Fast: New And Strategic Ways To Prune Your Portfolio

 
• By 

AI and machine learning can help companies push failures further up to avoid costly late-stage disappointments.

Johnson & Johnson Vision: Diverse Market Inputs ‘Make Us Smarter’ – EMEA President

 
• By 

Overseeing the diverse EMEA region as the regional president of Johnson & Johnson’s Vision business has been a whirlwind of activity for Jacqueline Henderson, in her role since 2023. Fresh back from the ESCRS 2024 meeting, she spoke to In Vivo about how J&J responds to market needs.

Market Access


Amgen’s Surprise Aflibercept Launch Shakes Up US Biosimilars In 2024

 
• By 

As the US biosimilars market approaches the end of its first decade, it has seen another busy year, with Amgen’s surprise launch of a rival to Eylea shaking up expectations as other first-time approvals rolled in throughout 2024. Meanwhile, competition to Stelara is waiting in the wings from the start of 2025.